1. USP7 counteracts SCFβTrCP- but not APCCdh1-mediated proteolysis of Claspin
- Author
-
Jiri Bartek, Simon Bekker-Jensen, Niels Mailand, Helene Faustrup, and Jiri Lukas
- Subjects
Cell cycle checkpoint ,DNA damage ,Regulator ,Biology ,Anaphase-Promoting Complex-Cyclosome ,Cell Line ,Substrate Specificity ,Ubiquitin-Specific Peptidase 7 ,Ubiquitin ,Report ,Humans ,CHEK1 ,Phosphorylation ,Mitosis ,Research Articles ,Adaptor Proteins, Signal Transducing ,SKP Cullin F-Box Protein Ligases ,G1 Phase ,Ubiquitination ,Ubiquitin-Protein Ligase Complexes ,Signal transducing adaptor protein ,Cell Biology ,Cell biology ,Checkpoint Kinase 1 ,Cancer research ,biology.protein ,Protein Kinases ,Ubiquitin Thiolesterase ,DNA Damage - Abstract
Claspin is an adaptor protein that facilitates the ataxia telangiectasia and Rad3-related (ATR)-mediated phosphorylation and activation of Chk1, a key effector kinase in the DNA damage response. Efficient termination of Chk1 signaling in mitosis and during checkpoint recovery requires SCF(betaTrCP)-dependent destruction of Claspin. Here, we identify the deubiquitylating enzyme ubiquitin-specific protease 7 (USP7) as a novel regulator of Claspin stability. Claspin and USP7 interact in vivo, and USP7 is required to maintain steady-state levels of Claspin. Furthermore, USP7-mediated deubiquitylation markedly prolongs the half-life of Claspin, which in turn increases the magnitude and duration of Chk1 phosphorylation in response to genotoxic stress. Finally, we find that in addition to the M phase-specific, SCF(betaTrCP)-mediated degradation, Claspin is destabilized by the anaphase-promoting complex (APC) and thus remains unstable in G1. Importantly, we demonstrate that USP7 specifically opposes the SCF(betaTrCP)- but not APC(Cdh1)-mediated degradation of Claspin. Thus, Claspin turnover is controlled by multiple ubiquitylation and deubiquitylation activities, which together provide a flexible means to regulate the ATR-Chk1 pathway.
- Published
- 2009
- Full Text
- View/download PDF